PATENT CLAIM ANALYSIS

Application Number: 15750128
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "412000"]

Abstract:
The disclosure provides compounds having formula (I), wherein the substituents are as defined herein. The compounds are useful for modulating the dopamine D 3  receptor and for treating conditions associated therewith, such as addictions, drug dependency, and psychiatric conditions.

Claim (Index 33):
The method of  claim 31  or  32 , wherein modulating the dopamine D 3  receptor is treating a medical condition that is impacted by the dopamine D 3  receptor.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15583679', '15272114', '13613344', '12664394', '11911035']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8329083309785374
- 35 USC 102 Novelty (BERT): 0.5444594704186327
- Combined Prediction Score: 0.804063444922547
- Mean Citation Score: 389.650642
- Max Citation Score: 434.1038
- Similarity Product: 240.70863534150124

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test